The RECOVER Long COVID study at Boston Medical Center seeks to understand, treat, and prevent the long-term effects of COVID-19. Part of nationwide effort, we are currently enrolling patients in a Boston-based study cohort to support research that will develop new approaches to diagnosis and treatment. Learn more about the RECOVER Long COVID Study.

"It’s important that we work to expand our knowledge about the long-term impacts of the COVID-19 virus in order to address — and help prevent — another public health crisis. This consortium will help us gather the data necessary to better understand the spectrum of how this virus presents in individuals, including among vulnerable populations that were hardest hit by COVID-19."

- Nahid Bhadelia, MD, MALD,
Infectious Disease Expert and Co-Principal Investigator of Boston Medical Center RECOVER study cohort

About the BMC RECOVER Study

The RECOVER study at Boston Medical Center seeks to understand, treat, and prevent the long-term effects of COVID-19. Our study is part of a national cohort funded by the National Institute for Health (NIH) with the goal of fully understanding the condition referred to as “post-acute sequelae of SARS-CoV-2” (PASC), or “long COVID.” The RECOVER (Research COVID to Enhance Recovery) study believes that:

Progress takes people like you

If you are currently or have been infected with COVID-19, we invite you to participate in this study to help scientists learn more about the effects of infection on long-term health. Our study team is committed to learning more, and your participation is crucial to helping scientist gain a deeper understanding of Long Covid. 

Progress takes inclusion

We are currently enrolling patients from the inpatient and outpatient settings of Boston Medical Center, patients of the ReCOVer Long Covid Clinic, and patients from community health centers throughout the Boston area.

Progress takes coordinated action

Our study is part of a nationwide consortium of hospitals and institutions coming together to learn more about the long-term effects of COVID-19. Across Boston, we are one of the hospitals joining the network of hospitals funded by the National Institute of Health (NIH) to carry out this study.

What is Long COVID?

Given the number of patients who have been or will be infected with SARS-CoV-2, the public health impact of PASC could be very large. Despite recovery from initial infection, many patients continue to experience a number of symptoms — including fatigue, shortness of breath, brain fog, sleep disorders, fevers, gastrointestinal symptoms, abnormal blood clotting, loss of taste and/or smell, anxiety, and depression. These symptoms collectively are now referred to as a condition called post-acute sequelae of SARS-CoV-2” (PASC), or “long COVID.” 

Even if someone did not experience symptoms during their initial infection, PASC is still relevant because a patient could still experience long-term effects after acute infection. 

For participants

  • If you are interested in learning more about our RECOVER Long Covid study at BMC, please fill out the form below and we will be in touch.
  • You may also email us directly at BMCRecover@bmc.org or call us at 617.414.8282

Participate


Thank You

Thank you for your interest in this study. Unfortunately, we are only enrolling patients who have previously tested positive for COVID. We thank you for your interest in this study

Long COVID Study Form
Please fill out the form below to get more information about participating in our Long COVID Study.









Study Team

Nahid Bhadelia, MD

Founding Director, Boston University Center for Emerging Infectious Diseases Policy and Research (CEID); Associate Director, National Emerging Infectious Diseases Laboratories (NEIDL); Associate Professor, Boston University Chobanian & Avedisian School of MedicineInfectious Diseases, Boston University Chobanian & Avedisian School of Medicine
Nahid Bhadelia Headshot 2020

Jai G Marathe, MD

Outpatient Medical Director, Center for Infectious Diseases, Assistant Professor of Medicine, Boston University Chobanian & Avedisian School of Medicine

Anna M Cervantes-Arslanian, MD

Director of Neurocritical Care & Associate Professor of Neurology and Neurosurgery, Boston University Chobanian & Avedisian School of Medicine
Placeholder image for doctor

George T O'Connor, MD

Director, Adult Asthma Program, , Professor of Medicine, Boston University Chobanian & Avedisian School of Medicine,

Naomi M Hamburg, MD

Professor of Medicine, Boston University Chobanian & Avedisian School of Medicine
Naomi Hamburg MD

Tracy A Battaglia, MD, MPH

Associate Director, Belkin Breast Health Center, Director, Women's Health Unit, General Internal Medicine, Associate Professor of Medicine, Boston University Chobanian & Avedisian School of Medicine,

Charles T Williams, MD

Vice Chair for Clinical Affairs and Quality Division of Family Medicine, Assistant Professor of Family Medicine, Boston University Chobanian & Avedisian School of Medicine

Caitryn McCallum
Liz Duffy, MA
Associate Professor, Pathology & Laboratory Medicine, Boston University School of Medicine
Director, Master Program in Pathology Laboratory Sciences
Director, Laboratory & Biorepository Research Services Core (LABS Core)

Caitryn McCallum
Caitryn McCallum, MPH
Study Manager, RECOVER
Director of Research & Partnerships, CEID

Misaki headshot

Misaki Kobayashi, MPH
Clinical Research Coordinator, RECOVER

Shubhi Sharma
Shubhi Sharma, MPH
Clinical Research Assistant, RECOVER

Partners

Latest Updates

Please check back for the latest updates from our study team.

Contact Us

  • Are you a member of the media or press? Please direct inquiries to the BMCRecover@bmc.org.
  • For more information about partnering with us on this study or for further questions, please call 617.414.8282 or email us at BMCRecover@bmc.org 
  • To contact the ReCOVer Long COVID Clinic at BMC, please click here.